Opening Brief in Second Circuit Securities Fraud Appeal

Today, the firm partnered with Pomerantz LLP to file the opening brief in an appeal in a securities fraud case involving generic pharmaceutical makers.

Previous
Previous

Eleventh Circuit Declines to Rehear Firm’s Copyright Victory Against Apple

Next
Next

Firm Seeks Supreme Court Review in Commodities Fraud Case